Market Overview

TickPick Acquires Leading Ticket Search Aggregator

TickPick Acquires Leading Ticket Search Aggregator

TickPick, a no-fee ticket marketplace, reached an agreement to buy a significant portion of the assets of Rukkus, a ticket inventory aggregator.

What Happened

Rukkus' platform allows users to perform aggregated searches of ticket buyers that cater to their interests and find concert and other tickets based on value, a press release said. Under TickPick's umbrella, it will continue to offer more than 300,000 customers access to cheap tickets and good deals for events all across the United States.

TickPick's acquisition is inline with the founders and co-CEOs Christopher O'Brien and Brett Goldberg vision of addressing the inefficiencies in the ticket marketplace and build a more transparent and cost-effective solution.

Why It's Important

One of the more notable aspects of the acquisition is TickPick's access to Rukkus' high-definition 360-degree views of hundreds of entertainment and sport venues. This feature gives users an accurate preview of what an event experience would look like from a chosen seat. The technology will be integrated into TickPick's platform and Rukkus users will be transitioned to TickPick's app for an optimal experience.

What's Next

"This purchase and our recent acquisition of established player Razorgator are part of our customer growth strategy and our focus on refining our tech to remain the premier site to buy sports and entertainment tickets," Goldberg said in the press release.

Related Links:

Patriots Fan Buys Super Bowl LII Tickets Using...

Lakers Ticket Prices Skyrocket As LeBron James Moves Into Town

Posted-In: concert tickets Concerts Rukkus Sports TicketsM&A News Sports General Best of Benzinga


Related Articles (LYV)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

EUR/USD Forecast: Perfect Wedge Implies An Explosive Move Ahead

Benzinga's Daily Biotech Pulse: Celgene's Lymphoma Trial Meets Endpoint, Merit Medical's Strong Q2, Bluebird Bio Offering